Lifestyle medicine uses evidence-based therapeutic lifestyle interventions to help prevent and treat chronic conditions – and a 12-week trial of the programme, funded by AIA NZ and developed by PREKURE, an organisation focused on preventative lifestyle medicine, found 100 per cent of participants who elected to share data achieved reduced blood sugar levels through its diabetes programme. Half achieved a clinically significant reduction in their blood sugar levels.
The trial was for a group of AIA NZ customers managing Type 2 diabetes or who were pre-diabetic. Grant Schofield, PREKURE Chief Science Officer, says diabetes diagnoses are on the rise, putting a strain on the healthcare system – but diet and lifestyle changes can achieve significant health improvements.
“Approximately one in 20 New Zealanders has been diagnosed with type 2 diabetes. By 2040, this is projected to almost double to one in 10. This will undoubtedly impose a huge burden both on our health system and Kiwi families.
“But it doesn’t have to be that way. PREKURE is centred on disease prevention through lifestyle medicine. The 12-week trial equipped participants with achievable diet changes, one-on-one health coaching, and group health coaching sessions to keep them focused and on track towards their goals,” says Schofield.
“Seeing all participants report a reduced blood sugar level – a key diabetes indicator – compared to when they started the trial was incredible. Participants also lost an average of 5kg in excess body weight throughout the trial, which was another fantastic outcome, demonstrating the dedication they had to the programme.
“Crucially, all those who participated in the trial are now better equipped to self-manage their diabetes or pre-diabetes diagnosis altogether.”